Med-Pharmex

Med-Pharmex is owned by Dechra Pharmaceuticals.

Dechra Pharmaceuticals is one of the...

• FTSE 350.

Dechra Pharmaceuticals is a company listed under the stock ticker DPH (GB).

Dechra Pharmaceuticals has a direct presence in 3 countries.

Acquisition, funding and merger involving Dechra Pharmaceuticals.

• Dechra Pharmaceuticals has announced the acquisition of Med-Pharmex  (posted on September 1 2022).

View the org chart displaying its 2 main executives

Most searched biographies at Med-Pharmex

• Gautam Shah, Vice President, Quality, Regulatory and Compliance
• Michael Park, Chief Financial Officer

Create your alert
to follow the executive moves at Med-Pharmex.

Dechra Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Med-Pharmex

Social media about Med-Pharmex

• Med-Pharmex on Wikipedia, Google News & Yahoo Finance
• Med-Pharmex on LinkedIn, Twitter & YouTube

Call Med-Pharmex at +1 909...

View the org chart

Register to receive your alert

Report an error